Korean J Otolaryngol-Head Neck Surg.  2004 Sep;47(9):833-836.

The Effect of Intratympanic Dexamethasone on Tinnitus in Inner Ear Diseases

• Sohn SJ
• Shin DW
• Kim WS

Abstract

BACKGROUND AND OBJECTIVES
Intratympanic steroid serves as a good therapeutic alternative for various inner ear diseases presenting with vertigo, hearing loss, and tinnitus. This study reports the effect of intratympanically injected dexamethasone (ITDEXA) on tinnitus in various cochlear pathologies. SUBJECTS AND METHOD: 19 patients with cochlear tinnitus (7 sudden sensorineural hearing loss (SSNHL), 5 noise induced hearing loss, 4 Meniere's disease and 3 acoustic trauma) were subjected to the IT-DEXA. The injection was performed with a spinal needle through the posterior superior quadrant of the tympanic membrane for 2 to 5 consecutive days. RESULTS: The overall improvement rate was 31.6%. Tinnitus was improved in 4 patients with SSNHL and 2 patients with Meniere's disease. Tinnitus was not improved in noise induced hearing loss or acoustic trauma. CONCLUSION: IT-DEXA is a therapeutic modality for tinnitus in SSNHL and Meniere's disease.

Keyword

Tinnitus; Middle ear; Dexamethasone; Injection

MeSH Terms

Acoustics
Dexamethasone*
Ear, Inner*
Ear, Middle
Hearing Loss
Hearing Loss, Noise-Induced
Hearing Loss, Sensorineural
Humans
Labyrinth Diseases*
Meniere Disease
Needles
Noise
Pathology
Tinnitus*
Tympanic Membrane
Vertigo
Dexamethasone